| Sep 4 |
AbbVie Stock Up Almost 20% in 3 Months: Buy, Sell or Hold?
|
| Sep 4 |
AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia
|
| Sep 4 |
Is AbbVie Inc. (ABBV) the Best Cancer Stock to Buy Now?
|
| Sep 3 |
Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring
|
| Sep 2 |
AbbVie Inc (ABBV): A Good 52-Week High Stock to Buy According to Short Sellers
|
| Sep 2 |
2 Dividend Stocks You Can Safely Hold Through a Recession
|
| Sep 1 |
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
|
| Aug 31 |
Investors in AbbVie (NYSE:ABBV) have seen solid returns of 262% over the past five years
|
| Aug 30 |
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
|
| Aug 30 |
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
|
